Management of Persistent Upper Body Rash Unresponsive to Initial Treatment

Immediate Assessment and Referral Criteria

For a rash on the upper body that has not improved after one week of antihistamines and steroids, the next step is dermatology referral for definitive diagnosis, as the failure to respond suggests either a non-allergic etiology, a severe drug reaction requiring specialist management, or an underlying condition that requires biopsy and targeted therapy, according to the Journal for ImmunoTherapy of Cancer 1
Rule out severe cutaneous reactions including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug rash with eosinophilia and systemic symptoms (DRESS), which require immediate drug discontinuation and specialist consultation, as recommended by the Annals of Internal Medicine and MMWR Recommendations and Reports 2, 3
Check for systemic involvement by obtaining complete blood count with differential, comprehensive metabolic panel, and assessing for fever, mucous membrane involvement, or multi-organ symptoms, as suggested by the Journal for ImmunoTherapy of Cancer 1

Refer to dermatology urgently if the rash covers >30% body surface area, as recommended by the journal Drugs 4
Refer to dermatology non-urgently if the rash persists despite appropriate topical therapy, the diagnosis is uncertain, or the rash significantly impacts quality of life despite covering <30% body surface area, according to the journal Drugs and BMJ 4, 6
Escalate topical therapy by applying high-potency topical corticosteroids to the body twice daily, using low-potency corticosteroids for facial involvement, and adding emollients liberally, as recommended by the Journal for ImmunoTherapy of Cancer and Drugs 1, 4
Consider secondary infection and add topical antibiotics or oral antibiotics if signs of superinfection are present, as suggested by the journal Drugs and Annals of Oncology 4, 5
Optimize antihistamine therapy by switching to or adding sedating antihistamines at bedtime if pruritus is prominent, as recommended by the Annals of Oncology and BMJ 5, 6

Do not continue ineffective treatment beyond 2 weeks, as persistent rashes unresponsive to initial therapy require diagnostic reassessment, not treatment escalation alone, according to the Annals of Oncology and Drugs 5, 4
Avoid prophylactic corticosteroids or antihistamines if considering drug-induced etiology, as these have not proven effective for prevention and may complicate diagnosis, as recommended by the Annals of Internal Medicine and MMWR Recommendations and Reports 2, 3